Abstract:Boron-enhanced proton therapy has recently appeared as a promising approach to increase the efficiency of proton therapy on tumor cells, and this modality can further be improved by the use of boron nanoparticles (B NPs) as local sensitizers to achieve enhanced and targeted therapeutic outcomes. However, the mechanisms of tumor cell elimination under boron-enhanced proton therapy still require clarification. Here, we explore possible molecular mechanisms responsible for the enhancement of therapeutic outcomes under boron NP-enhanced proton therapy. Spherical B NPs with a mode size of 25 nm were prepared by methods of pulsed laser ablation in water, followed by their coating by polyethylene glycol to improve their colloidal stability in buffers. Then, we assessed the efficiency of B NPs as sensitizers of cancer cell killing under irradiation with a 160.5 MeV proton beam. Our experiments showed that the combined effect of B NPs and proton irradiation induces an increased level of superoxide anion radical generation, which leads to the depolarization of mitochondria, a drop in their membrane mitochondrial potential, and the development of apoptosis. A comprehensive gene expression analysis (via RT-PCR) confirmed increased overexpression of 52 genes (out of 87 studied) involved in the cell redox status and oxidative stress, compared to 12 genes in the cells irradiated without B NPs. Other possible mechanisms responsible for the B NPs-induced radiosensitizing effect, including one related to the generation of alpha particles, are discussed. The obtained results give a better insight into the processes involved in the boron-induced enhancement of proton therapy and enable one to optimize parameters of proton therapy in order to maximize therapeutic outcomes.

Enhancing Proton Therapy Efficacy Through Nanoparticle-Mediated Radiosensitization

Synthetic nanoparticles for delivery of radioisotopes and radiosensitizers in cancer therapy

Radiation-assisted Strategies Provide New Perspectives to Improve the Nanoparticle Delivery to Tumor.

Recent Advances in Metal-Based NanoEnhancers for Particle Therapy

Enhancing X‐Ray Sensitization with Multifunctional Nanoparticles

Advances of Nanomedicine in Radiotherapy

Emerging Strategies of Nanomaterial‐Mediated Tumor Radiosensitization

Targeted Delivery of Nano-Radiosensitizers for Tumor Radiotherapy

Engineering nanoparticles to reprogram radiotherapy and immunotherapy: recent advances and future challenges

Emerging Nanoradiosensitizers and Nanoradioprotectants for Enhanced Cancer Theranostics

Boron Nanoparticle-Enhanced Proton Therapy: Molecular Mechanisms of Tumor Cell Sensitization

PROTAC Prodrug-Integrated Nanosensitizer for Potentiating Radiation Therapy of Cancer

Enhancement of Radiosensitization by Metal-Based Nanoparticles in Cancer Radiation Therapy

Tailoring Bismuth-Based Nanoparticles for Enhanced Radiosensitivity in Cancer Therapy

Tailoring Bi-based Nanoparticles for Enhanced Radiosensitivity in Cancer Therapy

Empowering Radiotherapy: Harnessing Nanomedicines to Enhance Radiation Response and Boost Antitumor Efficacy

Multifunctional High-Z Nanoradiosensitizers for Multimodal Synergistic Cancer Therapy.

Promoting Reactive Oxygen Species Generation: a Key Strategy in Nanosensitizer-Mediated Radiotherapy

Harnessing the Power of Nanotechnology for Enhanced Radiation Therapy

Co-Adjuvant Nanoparticles for Radiotherapy Treatments of Oncological Diseases

Delivery of therapeutic radioisotopes using nanoparticle platforms: potential benefit in systemic radiation therapy.